Zevra Therapeutics Inc
ZVRAHealthcare|Biotechnology|USA
$13.34
-0.59 (-4.23%)
Tangible Book
$3.30
Upcoming Data Readouts (1)
Jan 2027
Est. completion
P2Medium-chain Acyl-CoA Dehydrogenase Deficiency
Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Pediatric and Adults Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)
NCT06773026n=24